Karimpour (2014) have better adhesion to the perception of Aspirin love brand, that is, a functional brand. Design …

alone or in combination with aspirin is more effective in reducing the risk of atherothrombotic events than aspirin alone in …:Objective: To evaluate the cost effectiveness of 1 year of treatment with clopidogrel in addition to aspirin in NSTEMI or UA … aspirin treatment group and 8.41 years in the aspirin plus clopidogrel treatment group. The corresponding discounted QALYs …

We tested whether friends’ and family members’ cardiovascular health events and also their own aspirin use are … associated with the likelihood that an individual takes aspirin regularly. Analyses were based on longitudinal data on 2724 … also participants in the same study. Men were more likely to take aspirin if a male friend had recently been taking aspirin …

efficacy in the secondary prevention of atherothrombotic events. Although clopidogrel seems to be superior to aspirin in terms … aspirin in the secondary prevention of atherothrombotic events in patients with peripheral artery disease, a recent stroke or … 11.83 (95% CI 11.40, 12.22) years and 12.17 (95% CI 11.75, 12.55) years in the aspirin and clopidogrel treatment groups …

acetylsalicylic acid (aspirin) and clopidogrel have been shown to reduce the risk of recurrent cardiovascular events in various … subgroups of patients with vascular disease. Objective: To estimate the cost effectiveness of clopidogrel versus aspirin in … compared with aspirin during a patient's lifetime. A societal perspective was used, with costs stated in Swedish kronor (SEK …

the Markov model subsequently used suggest that aspirin (acetylsalicylic acid) dominates placebo for the secondary …, in periods or patients with elevated risk, more intensive treatment with clopidogrel (alone or together with aspirin) is … cost effective compared with aspirin alone for the secondary prevention of ischaemic events. For secondary stroke …

Background: Low-dose aspirin (acetylsalicylic acid) is standard care in patients with a history of cardiovascular … disease (CVD). The use of low-dose aspirin in primary prevention is not yet fully established, although meta-analyses and US … assess the economic consequences of the use of low-dose aspirin in the primary prevention of CVD in four European countries …